About Skye Bioscience

About company

Skye Bioscience is a biopharmaceutical company focused on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids, designed to alleviate a variety of diseases and symptoms by selectively targeting CB1 and CB2 receptors. Skye Bioscience is developing a novel and proprietary class of product candidates that are designed to target the body's nervous and immune systems without inducing many of the undesirable side effects typically associated with currently available therapeutics.